Acetylcarnitine increases membrane cytoskeletal protein-protein interactions

D. Allan Butterfield, Anuradha Rangachari

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Electron paramagnetic resonance has been used to investigate the effects of interaction of acetylcarnitine with cytoskeletal proteins in human erythrocyte membranes. This compound, currently in clinical trials as a potential therapeutic agent for Alzheimer's disease, caused a highly significant increase in cytoskeletal protein-protein interactions. Carnitine, the parent compound, also increased cytoskeletal protein-protein interactions, suggesting that the acetyl group is not hydrophobic enough to direct acetylcarnitine to the bilayer phase of the membrane. Consistent with this suggestion, no change in lipid order or dynamics with acetylcarnitine was observed. These results are discussed in terms of possible implications to Alzheimer's disease treatment.

Original languageEnglish
Pages (from-to)297-303
Number of pages7
JournalLife Sciences
Volume52
Issue number3
DOIs
StatePublished - 1993

Bibliographical note

Funding Information:
This work was supported in part by grants from NSF (EHR-91-08764) and NIH (AG-10836).

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (all)
  • Pharmacology, Toxicology and Pharmaceutics (all)

Fingerprint

Dive into the research topics of 'Acetylcarnitine increases membrane cytoskeletal protein-protein interactions'. Together they form a unique fingerprint.

Cite this